The DOI matches its Crossref record.
Interleukin‐6 and interleukin‐1 receptor antagonist in acute stroke
Abstract
Elevated plasma levels of interleukin‐6 (IL‐6), a key regulator of the acute phase response that includes increased fibrinogen synthesis, have recently been detected in patients with acute stroke. Nevertheless, the role of the acute phase response in stroke has been controversial, with some studies suggesting that preexisting infection accounts for most of the acute phase response. Increased IL‐6 could signal the involvement of antiinflammatory activity, since IL‐6 stimulates the production of endogenous antiinflammatory mediators such as interleukin‐1 receptor antagonist (IL‐1RA). To better understand the interaction of pro‐ and antiinflammatory acute phase processes in brain infarction, plasma levels of IL‐1RA, IL‐6, and acute phase proteins including fibrinogen and c‐reactive protein (CRP) were measured within 4 ± 2 days of onset in 50 patients with acute ischemic stroke and in 20 age‐matched healthy controls. After excluding patients with evidence of infection, both IL‐1RA and IL‐6 were significantly elevated in stoke patients compared with controls (p<0.0001). IL‐1RA and IL‐6 were both significantly correlated with levels of CRP, p<0.05 and p<0.001, respectively, but not with each other. Levels of IL‐6 and IL‐1RA, together with fibrinogen and CRP were higher in patients with infarcts of greater than 3 cm and lowest in patients with lacunar syndromes. Detection of increased peripheral levels of IL‐1RA, IL‐6, and additional acute phase reactants, including CRP, in acute stroke uncomplicated by infection suggests that an acute phase response to brain infarction occurs and that the magnitude of this response may be related to the volume of infarcted brain.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin-6, a Major Cytokine in the Central Nervous System
Erta, M., Quintana, A., & Hidalgo, J. (2012) · International Journal of Biological Sciences · doi:10.7150/ijbs.4679 · Cited by 1,087
INTERLEUKIN-1 RECEPTOR ANTAGONIST: Role in Biology
Arend, W. P., Malyak, M., Guthridge, C. J., & Gabay, C. (1998) · Annual Review of Immunology · doi:10.1146/annurev.immunol.16.1.27 · Cited by 1,071
Interleukin-1 and neuronal injury
Allan, S. M., Tyrrell, P. J., & Rothwell, N. J. (2005) · Nature Reviews Immunology · doi:10.1038/nri1664 · Cited by 992
Inflammation and glial responses in ischemic brain lesions
Stoll, G. (1998) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00034-3 · Cited by 795
The immunology of acute stroke
Chamorro, Á., Meisel, A., Planas, A. M., Urra, X., van de Beek, D., & Veltkamp, R. (2012) · Nature Reviews Neurology · doi:10.1038/nrneurol.2012.98 · Cited by 707
Metadata
- Authors
- Beamer, N. B., Coull, B. M., Clark, W. M., Hazel, J. S., & Silberger, J. R.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 1995-06
- Volume
- 37
- Issue
- 6
- Pages
- 800-805
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2017812906
- Cited by
- 231
- References
- 0
- FWCI
- 10.26
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Interleukin‐6 and interleukin‐1 receptor antagonist in acute stroke. https://app.cochat.ai/papers/10.1002/ana.410370614
- The paper
- Beamer, N. B., Coull, B. M., Clark, W. M., Hazel, J. S., & Silberger, J. R. (1995). Interleukin‐6 and interleukin‐1 receptor antagonist in acute stroke. Annals of Neurology. https://doi.org/10.1002/ana.410370614
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.